CoChat

Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours

Pirker, Robert A., Pont, Jörg, Pöhnl, Rainer, Schütz, Wolfgang, Griesmacher, Andrea, Müller, Matthias M. · 1998 · cclm
Cited by 51

The DOI matches its Crossref record.

Abstract

It is well known that peptide-producing endocrine tumours cosecrete immunoreactive chromogranin A with their characteristic hormones. Into this study 187 patients with the diagnosis malignant carcinoids or other malignancies were entered. Using chromogranin A at a cut-off level of 30.3 U/ml it was possible to discriminate between patients in remission and patients suffering a relapse with a sensitivity of 91.7% and a specificity of 96.4 %, which may be of important diagnostic value. In our study that lasted over one year we could clearly show that the measurement of chromogranin A is impressively superior to 5-hydroxyindoleacetic-acid for detecting a relapse of carcinoids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm.1998.147

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 51

Metadata

Authors
Pirker, R. A., Pont, J., Pöhnl, R., Schütz, W., Griesmacher, A., & Müller, M. M.
Venue
cclm
Published
1998-11-01
Volume
36
Issue
11
Pages
837-840
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W2051631475
Cited by
51
References
0
FWCI
0.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours. https://app.cochat.ai/papers/10.1515/cclm.1998.147
The paper
Pirker, R. A., Pont, J., Pöhnl, R., Schütz, W., Griesmacher, A., & Müller, M. M. (1998). Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours. cclm. https://doi.org/10.1515/cclm.1998.147

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.